About this episode
In 2023, you’d be hard-pressed to find a Wall Street analyst who wasn’t in love with Lululemon. The stock was a classic example of a long-term, buy-and-hold winner, with a strong brand, enviable profit margins, and plenty of expansion opportunities.However, coming into 2025, the company’s façade started to crack, with revenue growth slowing to single digits and comparable in-store sales falling. It appears the American market may be reaching saturation, with competition hot on Lulu’s heels. On top of that, tariffs are taking a healthy bite out of the bottom line, leaving its EBITDA “on the floor.” The stock is now the worst-performing name on the S&P 500 in 2025.That said, international markets—particularly in China—remain vibrant, and Lulu hopes to reinvigorate domestic sales through R&D innovation. Is the market’s pricing an overreaction, or a reasonable adjustment for a brand transitioning from growth to value?Mike also touches on Microsoft’s agreement with recent IPO Nebius, which sent the stock soaring.Prophet, MyWallSt's latest investing service, is focused on delivering market-beating in less than 5 minutes a month.We are running a seven day free trial for our followers.No commitment, cancel anytime.Click here to grab your trial.Become a successful investor by checking out all the content MyWallSt has to offer:? Email us: pod@mywallst.com? Learn the fundamentals of investing by downloading our free Learn app: https://bit.ly/3DXPOz7? Keep updated on stock market news by visiting our blog: https://mywallst.com/blog/? Tune in to our podcast Stock Club to stay updated on weekly news: https://mywallst.com/stock-investment-podcast/? Follow MyWallSt on social:? X: @MyWallStHQ? TikTok: @MyWallSt? Instagram: @MyWallSt?? Facebook: @MyWallSt? LinkedIn: MyWallSt
